Stem-loop compositions and methods for inhibiting vascular endothelial growth factor
US-12540330-B2 · Feb 3, 2026 · US
Erickson Carl is listed as an inventor on 9 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Erickson Carl |
| Total patents | 9 |
| First publication | Jan 31, 2019 |
| Latest publication | Feb 3, 2026 |
Publications ranked by popularity score, then publication date.
US-12540330-B2 · Feb 3, 2026 · US
US-2025321240-A1 · Oct 16, 2025 · US
US-12372544-B2 · Jul 29, 2025 · US
US-11466276-B2 · Oct 11, 2022 · US
US-2022098591-A1 · Mar 31, 2022 · US
US-2021396774-A1 · Dec 23, 2021 · US
US-2020216849-A1 · Jul 9, 2020 · US
US-10428330-B2 · Oct 1, 2019 · US
US-2019032056-A1 · Jan 31, 2019 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Albert Einstein College Medicine Inc | 4 |
| Albert Einstein College Medicine | 4 |
| Beckman Coulter Inc | 3 |
| Vitrisa Therapeutics Inc | 3 |
| Drive Therapeutics Llc | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N15/115 | 6 |
| C12N2310/531 | 6 |
| C12N2310/16 | 6 |
| A61K31/7088 | 4 |
| C12N2310/322 | 4 |